Application of ibrutinib in treating ovarian cancer
The embodiment discloses application of ibrutinib to treatment of ovarian cancer. The application is selected from inhibition of proliferation of ovarian cancer cells, inhibition of dryness of ovarian cancer stem cells or improvement of sensitivity of the ovarian cancer cells to cis-platinum. The embodiment of the invention further discloses application of the ibrutinib and cis-platinum crop composition to treatment of ovarian cancer. The embodiment of the invention also discloses an application of ibrutinib in targeting deubiquitinase ovarian cancer cells. The embodiment of the invention further discloses application of ibrutinib in preparation of drugs for inhibiting phosphorylated JNK protein expression in ovarian cancer cells..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Europäisches Patentamt - (2024) vom: 19. Jan. Zur Gesamtaufnahme - year:2024 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
ZHANG WEI [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Themen: |
Sonstige Themen: |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2024-01-19, Last update posted on www.tib.eu: 2024-04-30, Last updated: 2024-05-03 |
|---|
| Patentnummer: |
CN117414366 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA002744740 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA002744740 | ||
| 003 | DE-627 | ||
| 005 | 20240503105854.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240329s2024 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA002744740 | ||
| 035 | |a (EPA)CN117414366 | ||
| 035 | |a (EPA)89532792 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a ZHANG WEI |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Application of ibrutinib in treating ovarian cancer |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2024-01-19, Last update posted on www.tib.eu: 2024-04-30, Last updated: 2024-05-03 | ||
| 520 | |a The embodiment discloses application of ibrutinib to treatment of ovarian cancer. The application is selected from inhibition of proliferation of ovarian cancer cells, inhibition of dryness of ovarian cancer stem cells or improvement of sensitivity of the ovarian cancer cells to cis-platinum. The embodiment of the invention further discloses application of the ibrutinib and cis-platinum crop composition to treatment of ovarian cancer. The embodiment of the invention also discloses an application of ibrutinib in targeting deubiquitinase ovarian cancer cells. The embodiment of the invention further discloses application of ibrutinib in preparation of drugs for inhibiting phosphorylated JNK protein expression in ovarian cancer cells. | ||
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a LI FENG |e verfasserin |4 aut | |
| 700 | 0 | |a CHEN YUROU |e verfasserin |4 aut | |
| 700 | 0 | |a QIANG YULONG |e verfasserin |4 aut | |
| 700 | 0 | |a FAN JIACHEN |e verfasserin |4 aut | |
| 700 | 0 | |a FAN GUANLAN |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2024) vom: 19. Jan. |
| 773 | 1 | 8 | |g year:2024 |g day:19 |g month:01 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/89532792/publication/CN117414366A1?q=CN117414366 |x 0 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 19 |c 01 | ||